Monocytic Leukemia

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML [Phase 2]

  Phase 2 clinical trial evaluating venetoclax in combination with cladribine and cytarabine alternating with azacitidine plus venetoclax for …

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating venetoclax in combination with a CACAG regimen versus the 3+7 regimen for acute monocytic leukemia is cu…

• CLINICAL_TRIALS research · 2025-12-19
  Clinical Trial Update: Cladribine Venetoclax in Monocytic AML [Phase 2]

  A Phase 2 clinical trial evaluating the combination of cladribine and venetoclax for monocytic acute myeloid leukemia, currently recruiting.

• CLINICAL_TRIALS research · 2025-11-21
  Clinical Trial Update: Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia [Phase 2]

  A Phase 2 clinical trial is evaluating the triple combination of venetoclax, azacitidine, and chidamide (VAC) for newly diagnosed acute mono…

• CLINICAL_TRIALS research · 2025-09-15
  Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]

  This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2016-05-19
  Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

  A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML p…